Funding for Global Cancer Research and Training
The Center for Global Health (CGH) funds research to reduce the global burden of cancer and offers research training opportunities for investigators to strengthen their research abilities.
Sort the table below for current funding opportunities for global cancer research and research training.
Learn more about grants and funding from the National Institutes of Health.
Current Funding Opportunities
| Title | Announcement Number | Opening Date | Due Date | Additional Resources |
|---|---|---|---|---|
| Notice of Intent to Publish a Notice of Funding Opportunity for Global Training for Research and Equity in Cancer (GlobTREC) (U2R Clinical Trial Optional) | NOT-CA-25-028 | 02/28/2025 | 07/14/2025 |
Estimated Publication Date of Notice of Funding Opportunity: February 28, 2025 |
| Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments | NOT-CA-25-012 | 12/27/2024 | 01/05/2025 |
See Notice for additional application due dates. Interested applicants must submit applications for this initiative using one of the following Dissemination and Implementation Research in Health NOFOs:
Reissue of NOT-CA-24-064 |
| Notice of Special Interest (NOSI): Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute | NOT-CA-24-098 | 09/10/2024 | 10/12/2024 | See Notice for additional application due dates. |
| Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings | NOT-CA-23-078 | 7/27/2023 | 10/17/2023 | See Notice for additional application due dates. |
| Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) | PAR-25-242 | 02/21/2025 | 03/21/2025 | See Notice for additional application due dates. |
| Co-infection and Cancer (R01 Clinical Trial Not Allowed) | PAR-25-082 | 01/05/2025 | 02/05/2025 | See Notice for additional application due dates. |
| Co-infection and Cancer (R21 Clinical Trial Not Allowed) | PAR-25-083 | 01/16/2025 | 02/16/2025 | See Notice for additional application due dates. |
| Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional) | PAR-25-213 | 01/07/2025 | 02/07/2025 | See Notice for additional application due dates. |
Training Opportunities
Explore cancer research programs and research training offered and funded through CGH.